Public option may decrease commercial plan premiums, study finds

Introducing a public health insurance option into markets could lower premiums among commercial payers, according to a study published by the left-leaning Urban Institute, funded by the Robert Wood Johnson Foundation.

Advertisement

Researchers studied how the presence of a Medicaid insurer in a specific region affected premiums offered by commercial plans like Blue Cross Blue Shield, provider-sponsored plans, and other national and local commercial payers.

Researchers found a link between the presence of a Medicaid plan and commercial payers offering lower premiums, according to the report. Specifically, when researchers looked only at the lowest marketplace premium offered by non-Medicaid insurers, they found a 40-year-old consumer in a market with at least one Medicaid insurer could see a $38 reduction in monthly premiums compared to the average for non-Medicaid insurers.

“These managed-care organizations, though not purely public options, represent a proxy for them,” the researchers note. Later, they write: “Though we do not suggest our models are sufficiently comprehensive to assess whether the relationship between Medicaid insurer presence and non-Medicaid insurer premiums is causal, our results suggest a causal relationship.”

Read the full report here.

More articles on payers:
CMS sanctions UnitedHealthcare plan: 3 things to know
UnitedHealth posts $5B profit in Q3
UnitedHealth, Optum offer care + coverage under new package

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Capital

Advertisement

Comments are closed.